vs
Axsome Therapeutics, Inc.（AXSM）与GRID DYNAMICS HOLDINGS, INC.（GDYN）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是GRID DYNAMICS HOLDINGS, INC.的1.8倍（$191.2M vs $104.1M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 3.7%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 12.0%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
AXSM vs GDYN — 直观对比
营收规模更大
AXSM
是对方的1.8倍
$104.1M
营收增速更快
AXSM
高出53.7%
3.7%
两年增速更快
AXSM
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $104.1M |
| 净利润 | — | $-1.5M |
| 毛利率 | — | 34.8% |
| 营业利润率 | -33.1% | 61.7% |
| 净利率 | — | -1.4% |
| 营收同比 | 57.4% | 3.7% |
| 净利润同比 | — | -150.6% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMGDYN
| Q1 26 | $191.2M | $104.1M | ||
| Q4 25 | $196.0M | $106.2M | ||
| Q3 25 | $171.0M | $104.2M | ||
| Q2 25 | $150.0M | $101.1M | ||
| Q1 25 | $121.5M | $100.4M | ||
| Q4 24 | $118.8M | $100.3M | ||
| Q3 24 | $104.8M | $87.4M | ||
| Q2 24 | $87.2M | $83.0M |
净利润AXSMGDYN
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $-28.6M | $306.0K | ||
| Q3 25 | $-47.2M | $1.2M | ||
| Q2 25 | $-48.0M | $5.3M | ||
| Q1 25 | $-59.4M | $2.9M | ||
| Q4 24 | $-74.9M | $4.5M | ||
| Q3 24 | $-64.6M | $4.3M | ||
| Q2 24 | $-79.3M | $-817.0K |
毛利率AXSMGDYN
| Q1 26 | — | 34.8% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | — | 35.6% |
营业利润率AXSMGDYN
| Q1 26 | -33.1% | 61.7% | ||
| Q4 25 | -13.8% | 0.5% | ||
| Q3 25 | -27.0% | -0.2% | ||
| Q2 25 | -24.5% | -0.1% | ||
| Q1 25 | -46.9% | -2.0% | ||
| Q4 24 | -61.1% | 1.3% | ||
| Q3 24 | -59.8% | 2.4% | ||
| Q2 24 | -89.5% | 0.0% |
净利率AXSMGDYN
| Q1 26 | — | -1.4% | ||
| Q4 25 | -14.6% | 0.3% | ||
| Q3 25 | -27.6% | 1.1% | ||
| Q2 25 | -32.0% | 5.2% | ||
| Q1 25 | -48.9% | 2.9% | ||
| Q4 24 | -63.1% | 4.5% | ||
| Q3 24 | -61.7% | 4.9% | ||
| Q2 24 | -91.0% | -1.0% |
每股收益（稀释后）AXSMGDYN
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $-0.55 | $0.01 | ||
| Q3 25 | $-0.94 | $0.01 | ||
| Q2 25 | $-0.97 | $0.06 | ||
| Q1 25 | $-1.22 | $0.03 | ||
| Q4 24 | $-1.54 | $0.06 | ||
| Q3 24 | $-1.34 | $0.05 | ||
| Q2 24 | $-1.67 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $327.5M |
| 总债务越低越好 | $70.0M | — |
| 股东权益账面价值 | — | $530.1M |
| 总资产 | $713.6M | $605.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMGDYN
| Q1 26 | $305.1M | $327.5M | ||
| Q4 25 | $322.9M | $342.1M | ||
| Q3 25 | $325.3M | $338.6M | ||
| Q2 25 | $303.0M | $336.8M | ||
| Q1 25 | $300.9M | $325.5M | ||
| Q4 24 | $315.4M | $334.7M | ||
| Q3 24 | $327.3M | $231.3M | ||
| Q2 24 | $315.7M | $256.0M |
总债务AXSMGDYN
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AXSMGDYN
| Q1 26 | — | $530.1M | ||
| Q4 25 | $88.3M | $542.1M | ||
| Q3 25 | $73.7M | $537.7M | ||
| Q2 25 | $73.1M | $532.2M | ||
| Q1 25 | $53.2M | $517.4M | ||
| Q4 24 | $57.0M | $517.8M | ||
| Q3 24 | $92.9M | $400.2M | ||
| Q2 24 | $102.9M | $388.4M |
总资产AXSMGDYN
| Q1 26 | $713.6M | $605.0M | ||
| Q4 25 | $689.8M | $612.9M | ||
| Q3 25 | $669.3M | $613.2M | ||
| Q2 25 | $639.8M | $608.9M | ||
| Q1 25 | $596.7M | $590.9M | ||
| Q4 24 | $568.5M | $592.2M | ||
| Q3 24 | $561.5M | $477.3M | ||
| Q2 24 | $548.2M | $443.6M |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
GDYN
暂无分部数据
